A rheumatologist discusses how her understanding of chronic pain in PsA has evolved—and how it affects her approach to ...

Biologics targeting interleukin (IL)-12, IL-23, and IL-17 may have valuable safety benefits among older adults with psoriatic disease, as a lower rate of serious infection was observed among these ...

Discover 5 insights about psoriatic arthritis from rheumatology experts, including pain management strategies, treatment ...

Medically reviewed by Stella Bard, MD Psoriatic arthritis (PsA) is a chronic (long-term) condition that includes symptoms of ...

Apremilast treatment in patients with psoriatic arthritis leads to favorable changes in body composition and improves disease ...

Psoriatic arthritis (PsA) differs in presentation ... We’re planning an electronic health records-based pragmatic trial to evaluate treatment responses in PsA [based on these clusters]." ...

“We also need to focus on early intensive treatment before damage sets in – there is a window of opportunity that we may be ...

The European Commission (EC) has granted marketing authorisation for Johnson & Johnson's (J&J) Tremfya (guselkumab) to treat ...

The following is a summary of “Association Between Patient Perception of Disease Status and Different Components of the ...

Researchers have established that uveitis (a severe inflammatory eye disease) is bidirectionally linked to psoriatic ...